Literature DB >> 10194768

HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.

C C Zhang1, S Krieg, D J Shapiro.   

Abstract

Estrogen receptor (ER) toxicity has hampered the development of vertebrate cell lines stably expressing substantial levels of recombinant wild-type ER. To isolate clonal lines of HeLa cells stably expressing epitope-tagged ER, we used a construction encoding a single bicistronic mRNA, in which FLAG-epitope-tagged human ER alpha (fER) was translated from a 5'-translation initiation site and fused to the neomycin resistance gene, which was translated from an internal ribosome entry site. One stable HeLa-ER-positive cell line (HeLa-ER1) produces 1,300,000 molecules of fER/cell (approximately 20-fold more ER than MCF-7 cells). The HeLa fER is biologically active in vivo, as judged by rapid death of the cells in the presence of either 17 beta-estradiol or trans-hydroxytamoxifen and the ability of the cell line to activate a transfected estrogen response element (ERE)-containing reporter gene. The FLAG-tagged ER was purified to near homogeneity in a single step by immunoaffinity chromatography with anti-FLAG monoclonal antibody. Purified fER exhibited a distribution constant (KD) for 17 beta-estradiol of 0.45 nM. Purified HeLa fER and HeLa fER in crude nuclear extracts exhibit similar KD values for the ERE (0.8 nM and 1 nM, respectively), which are approximately 10 times lower than the KD of 10 nM we determined for purified ER expressed using the baculovirus system. HMG-1 strongly stimulated binding of both crude and purified HeLa fER to the ERE (KD of 0.25 nM). In transfected HeLa cells, HMG-1 exhibited a dose-dependent stimulation of 17 beta-estradiol-dependent transactivation. At high levels of transfected HMG-1 expression plasmid, transactivation by ER became partially ligand-independent, and transactivation by trans-hydroxytamoxifen was increased by more than 25-fold. These data describe a system in which ER, stably expressed in HeLa cells and easily purified, exhibits extremely high affinity for the ERE, and suggest that intracellular levels of HMG-1 may be limiting for ER action.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194768     DOI: 10.1210/mend.13.4.0264

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  35 in total

1.  Mechanism for specificity by HMG-1 in enhanceosome assembly.

Authors:  K B Ellwood; Y M Yen; R C Johnson; M Carey
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  The role of trans-acting factors and DNA-bending in the silencing of human beta-globin gene expression.

Authors:  L R Drew; D C Tang; P E Berg; G P Rodgers
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

3.  Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors.

Authors:  Guy Verrijdt; Annemie Haelens; Erik Schoenmakers; Wilfried Rombauts; Frank Claessens
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

4.  Activation of estrogen receptor α by raloxifene through an activating protein-1-dependent tethering mechanism in human cervical epithelial cancer cells: a role for c-Jun N-terminal kinase.

Authors:  Elizabeth A Fogarty; Christina K Matulis; W Lee Kraus
Journal:  Mol Cell Endocrinol       Date:  2011-09-22       Impact factor: 4.102

Review 5.  Ménage à Trois in stress: DAMPs, redox and autophagy.

Authors:  Guanqiao Li; Daolin Tang; Michael T Lotze
Journal:  Semin Cancer Biol       Date:  2013-08-28       Impact factor: 15.707

Review 6.  HMGB1 release by inflammasomes.

Authors:  Lieselotte Vande Walle; Thirumala-Dev Kanneganti; Mohamed Lamkanfi
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

7.  Neuropeptide modulators of high mobility group box 1 secretion as potential therapeutic agents for severe sepsis.

Authors:  Mitchell P Fink
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

8.  Fluorescence anisotropy microplate assay to investigate the interaction of full-length steroid receptor coactivator-1a with steroid receptors.

Authors:  Chen Zhang; Steven K Nordeen; David J Shapiro
Journal:  Methods Mol Biol       Date:  2013

9.  Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements.

Authors:  Sarah C Roemer; Douglas C Donham; Lori Sherman; Vickie H Pon; Dean P Edwards; Mair E A Churchill
Journal:  Mol Endocrinol       Date:  2006-08-24

10.  Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.

Authors:  Jian-Hua Zhou; David V Yu; Jingwei Cheng; David J Shapiro
Journal:  Steroids       Date:  2007-07-07       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.